MWP
GSK icon

MYCIO Wealth Partners’s GSK GSK Stock Holding History

MYCIO Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-40,404
Closed -$2.37M – 176
2019
Q4 		$2.37M Buy
40,404
+6
+0% +$334 0.15% 66
2019
Q3 		$2.15M Sell
40,398
-102
-0.3% -$5.25K 0.16% 60
2019
Q2 		$2.03M Buy
40,500
+70
+0.2% +$3.51K 0.16% 58
2019
Q1 		$2.11M Sell
40,430
-40
-0.1% -$2K 0.17% 54
2018
Q4 		$1.93M Sell
40,470
-3,790
-9% -$187K 0.18% 56
2018
Q3 		$2.22M Sell
44,260
-2,873
-6% -$146K 0.22% 44
2018
Q2 		$2.38M Sell
47,133
-41
-0.1% -$2.06K 0.25% 43
2018
Q1 		$2.3M Sell
47,174
-1,505
-3% -$70.1K 0.26% 40
2017
Q4 		$2.16M Buy
48,679
+1,043
+2% +$48.2K 0.23% 42
2017
Q3 		$2.42M Sell
47,636
-16
-0% -$812 0.27% 38
2017
Q2 		$2.57M Sell
47,652
-19,768
-29% -$1.05M 0.3% 33
2017
Q1 		$3.55M Sell
67,420
-1,674
-2% -$84.9K 0.44% 28
2016
Q4 		$3.33M Buy
69,094
+1,627
+2% +$80.4K 0.45% 28
2016
Q3 		$3.64M Buy
67,467
+6,517
+11% +$357K 0.6% 19
2016
Q2 		$3.3M Buy
60,950
+546
+0.9% +$28.8K 0.57% 21
2016
Q1 		$3.06M Sell
60,404
-395
-0.6% -$19.7K 0.54% 24
2015
Q4 		$3.07M Buy
60,799
+501
+0.8% +$25.5K 0.55% 25
2015
Q3 		$2.9M Buy
60,298
+936
+2% +$48.7K 0.59% 21
2015
Q2 		$3.09M Buy
59,362
+5
+0% +$282 0.6% 19
2015
Q1 		$3.42M Buy
59,357
+1
+0% +$57 0.7% 17
2014
Q4 		$3.17M Sell
59,356
-14,289
-19% -$799K 0.67% 19
2014
Q3 		$4.23M Buy
73,645
+9,027
+14% +$553K 0.99% 13
2014
Q2 		$4.32M Sell
64,618
-4,905
-7% -$332K 0.98% 13
2014
Q1 		$4.64M Buy
69,523
+24,303
+54% +$1.64M 1.13% 10
2013
Q4 		$3.02M Buy
45,220
+15,578
+53% +$1.01M 0.75% 18
2013
Q3 		$1.86M Buy
29,642
+30
+0.1% +$1.93K 0.51% 24
2013
Q2 		$1.85M Buy
+29,612
New +$1.88M 0.51% 23

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

MYCIO Wealth Partners's GSK Position: Q1 2020 in Review

MYCIO Wealth Partners sold out of GSK (GSK) in Q1 2020, closing a stake of 40,404 shares — an estimated $2.37M sold.

MYCIO Wealth Partners first reported a position in GSK in Q2 2013 and held it in 27 quarters. The position peaked at $4.64M in Q1 2014. 818 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • MYCIO Wealth Partners reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • MYCIO Wealth Partners sold 40,404 GSK shares in Q1 2020, an estimated $2.37M.
  • MYCIO Wealth Partners first reported a position in GSK in Q2 2013 and held it in 27 quarters.
  • MYCIO Wealth Partners's GSK position peaked at $4.64M in Q1 2014.
  • 818 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on MYCIO Wealth Partners's 13F filing for Q1 2020, filed 14 May 2020.